glp-1 and mcas Could Medications Be a Game-Changer for MCAS? Understanding GLP-1 receptor agonists and

Yehuda Handelsman: Received research grants, consultant and speaker honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Eli Lilly, Ionis, Merck, Novo Nordisk, Regeneron, Sanofi, Verdiva Bio

The study design of these studies primarily aims at demonstrating non-inferiority (safety) of a novel substance compared to a control arm with standard of care excluding the novel drug

I have come to doctor Niketa with my teenage son with severe acne problem

Taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms

Spicy or acidic foods While flavorful foods may satisfy your taste buds, they can often irritate your stomach

elegans as an animal model to study the intersection of DNA repair, aging and neurodegeneration